We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

53 hedge funds and large institutions have $11.2M invested in Greenwich LifeSciences in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,297% more capital inflows, than outflows

Capital inflows: $1.61M | Capital outflows: $115K

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

10% more funds holding

Funds holding: 48 → 53 (+5)

0.38% more ownership

Funds ownership: 8.85% → 9.23% (+0.38%)

Holders
53
Holders Change
+5
Holders Change %
+10.42%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
20
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$534K
2
Millennium Management
Millennium Management
New York
+$325K
3
Goldman Sachs
Goldman Sachs
New York
+$157K
4
BlackRock
BlackRock
New York
+$143K
5
Renaissance Technologies
Renaissance Technologies
New York
+$141K

Top Sellers

Rank Fund Capital Flow
1
Corebridge Financial
Corebridge Financial
Texas
-$28.5K
2
Citigroup
Citigroup
New York
-$20.7K
3
Northern Trust
Northern Trust
Illinois
-$17.6K
4
UBS Group
UBS Group
Switzerland
-$12.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$12.4K

GLSI Hedge Fund Activity: Q2 2025 in Review

53 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2025, worth a combined $11.2M — up 0.78% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GLSI positions and 3 closed out — a net gain of 6 holders — while 20 added to existing stakes and 10 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $534K. The largest seller was Corebridge Financial, exiting entirely with an estimated $28.5K sold.

  • 53 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2025, up from 48 in Q1 2025.
  • Funds reported $11.2M of Greenwich LifeSciences stock for Q2 2025, up 0.78% quarter-over-quarter.
  • 9 funds opened new Greenwich LifeSciences positions in Q2 2025 and 3 closed out, a net change of +6 holders.
  • The largest Greenwich LifeSciences buyer in Q2 2025 was Marshall Wace, an estimated $534K added.
  • The largest Greenwich LifeSciences seller in Q2 2025 was Corebridge Financial, an estimated $28.5K sold.

Based on aggregated 13F filings for Q2 2025.